Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuemin Gu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Medical Research Methodology|June 8, 2010
A simulation study for comparing testing statistics in response-adaptive randomizationXuemin Gu, J Jack Lee
Contemporary Clinical Trials|October 1, 2013
Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpointsXuemin Gu, Guosheng Yin, J Jack Lee
Clinical Trials (London, England)|June 24, 2010
Bayesian adaptive randomization designs for targeted agent developmentJ Jack Lee, Xuemin Gu, Suyu Liu
Frontiers in Bioscience (Landmark Edition)|January 29, 2026
Long Non-Coding RNA <i>RAB11B-AS1</i> Suppresses Cervical Cancer Progression by Upregulating <i>RPL26</i> ExpressionXuemin Gu, Yuanyuan Yang, Zhixia Zhang, et al.
Plastic and Reconstructive Surgery|September 28, 2010
Reconstructive strategies for partial sacrectomy defects based on surgical outcomesPatrick B Garvey, Laurence D Rhines, Lei Feng, et al.
Frontiers in Oncology|September 30, 2022
A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancerJingshuai Wang, Xuemin Gu, Leilei Cao, et al.
International Journal of Nanomedicine|February 24, 2021
Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor TherapyJingshuai Wang, Xuemin Gu, Yiqin Ouyang, et al.
Statistics in Biosciences|September 13, 2016
Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy DevelopmentXuemin Gu, Nan Chen, Caimiao Wei, et al.
BMJ Open Ophthalmology|February 6, 2025
Effectiveness and safety of the XEN45 gel stent compared to trabeculectomy in primary open-angle glaucoma: the Gold-Standard Pathway StudyIqbal K Ahmed, Vanessa Vera, Ingeborg Stalmans, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 30, 2009
Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis systemHumam Kadara, Ludovic Lacroix, Carmen Behrens, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Medical Research Methodology|June 8, 2010
A simulation study for comparing testing statistics in response-adaptive randomizationXuemin Gu, J Jack Lee
Contemporary Clinical Trials|October 1, 2013
Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpointsXuemin Gu, Guosheng Yin, J Jack Lee
Clinical Trials (London, England)|June 24, 2010
Bayesian adaptive randomization designs for targeted agent developmentJ Jack Lee, Xuemin Gu, Suyu Liu
Frontiers in Bioscience (Landmark Edition)|January 29, 2026
Long Non-Coding RNA <i>RAB11B-AS1</i> Suppresses Cervical Cancer Progression by Upregulating <i>RPL26</i> ExpressionXuemin Gu, Yuanyuan Yang, Zhixia Zhang, et al.
Plastic and Reconstructive Surgery|September 28, 2010
Reconstructive strategies for partial sacrectomy defects based on surgical outcomesPatrick B Garvey, Laurence D Rhines, Lei Feng, et al.
Frontiers in Oncology|September 30, 2022
A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancerJingshuai Wang, Xuemin Gu, Leilei Cao, et al.
International Journal of Nanomedicine|February 24, 2021
Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor TherapyJingshuai Wang, Xuemin Gu, Yiqin Ouyang, et al.
Statistics in Biosciences|September 13, 2016
Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy DevelopmentXuemin Gu, Nan Chen, Caimiao Wei, et al.
BMJ Open Ophthalmology|February 6, 2025
Effectiveness and safety of the XEN45 gel stent compared to trabeculectomy in primary open-angle glaucoma: the Gold-Standard Pathway StudyIqbal K Ahmed, Vanessa Vera, Ingeborg Stalmans, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 30, 2009
Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis systemHumam Kadara, Ludovic Lacroix, Carmen Behrens, et al.
Pageof 2